
09/04/2025
We have some big news to share! Last week marked the first patient scanned in a first-in-human PET study using the tracer 18F-TRX, developed by Dr. Mike Evans and his team.
This clinical trial will explore how 18F-TRX can help detect cancers such as glioma, kidney cancer, and prostate cancer. By highlighting unstable iron levels within tumors, this tracer offers a promising new way to see cancer more clearly.
A huge thank you to the entire team—RPF, clinical research coordinators, nurses, nuclear medicine technologists, and physicians—for their dedication in making this milestone possible!
https://clinicaltrials.ucsf.edu/trial/NCT06942104